- Home
- NXJ vs PSNL Comparison
NXJ vs PSNL Comparison
Compare NXJ & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXJ
- PSNL
- Stock Information
- Founded
- NXJ 1999
- PSNL 2011
- Country
- NXJ United States
- PSNL United States
- Employees
- NXJ N/A
- PSNL 229
- Industry
- NXJ Finance/Investors Services
- PSNL Medical Specialities
- Sector
- NXJ Finance
- PSNL Health Care
- Exchange
- NXJ Nasdaq
- PSNL Nasdaq
- Market Cap
- NXJ 457.7M
- PSNL 478.0M
- IPO Year
- NXJ N/A
- PSNL 2019
- Fundamental
- Price
- NXJ $12.10
- PSNL $6.10
- Analyst Decision
- NXJ
- PSNL Strong Buy
- Analyst Count
- NXJ 0
- PSNL 4
- Target Price
- NXJ N/A
- PSNL $8.13
- AVG Volume (30 Days)
- NXJ 74.9K
- PSNL 844.2K
- Earning Date
- NXJ 01-01-0001
- PSNL 11-05-2025
- Dividend Yield
- NXJ 3.27%
- PSNL N/A
- EPS Growth
- NXJ N/A
- PSNL N/A
- EPS
- NXJ N/A
- PSNL N/A
- Revenue
- NXJ N/A
- PSNL $80,317,000.00
- Revenue This Year
- NXJ N/A
- PSNL N/A
- Revenue Next Year
- NXJ N/A
- PSNL $29.83
- P/E Ratio
- NXJ N/A
- PSNL N/A
- Revenue Growth
- NXJ N/A
- PSNL 0.36
- 52 Week Low
- NXJ $10.06
- PSNL $2.83
- 52 Week High
- NXJ $12.24
- PSNL $7.79
- Technical
- Relative Strength Index (RSI)
- NXJ 80.79
- PSNL 69.94
- Support Level
- NXJ $11.12
- PSNL $4.73
- Resistance Level
- NXJ $11.37
- PSNL $4.97
- Average True Range (ATR)
- NXJ 0.10
- PSNL 0.28
- MACD
- NXJ 0.08
- PSNL 0.16
- Stochastic Oscillator
- NXJ 98.35
- PSNL 90.33
About NXJ Nuveen New Jersey Qualified Municipal Fund
Nuveen New Jersey Quality Municipal Income Fund is a closed-end investment management company. Its objective is to provide current income exempt from regular federal and New Jersey income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued. The company invests a majority of its managed assets in securities rated, at the time of investment, investment grade or, if the bonds are unrated, are judged by the manager to be of comparable quality.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.